Transition metal complexes of 3-aryl-2-substituted 1,2-dihydroquinazolin-4(3H)-one derivatives: New class of analgesic and anti-inflammatory agents

Five-coordinate, neutral transition metal complexes of newly designed pyridine-2-ethyl-(3-carboxyhdeneamino)-3-(2-phenyl)-1,2-dihydroquinazoli n-4(3H)-one (L) were synthesized and characterized The structure of ligand is confirmed by single crystal X-ray diffraction studies The compounds were evaluated for the anti-inflammatory activity by carrageenan-induced rat paw edema model while their analgesic activity was determined by acetic acid-induced writhing test in mice wherein the transition metal complexes were found to be more active than the free ligand (C) 2010 Elsevier Masson SAS All rights reserved.

Synthesis of the lactone of 2-carboxy-4-hydroxy-7-methoxy-1, 2, 3, 4-tetrahydrophenanthrone

Starting from 6-methoxynaphthaldehyde-2, 2-carboxy-7-methoxy-1, 2, 3, 4-tetrahydrophenanthrone-4 was prepared. Sodium borohydride reduction of the keto-acid followed by chromic acid oxidation yielded the lactone of 2-carboxy-4-hydroxy-7-methoxy-1, 2, 3, 4-tetrahydrophenanthrone. Alkylation of the lactone of 2-carboxy-4-hydroxy-6-methoxytetralone was not promising.

Synthesis of 1,3-dimethyl-1,3-dicarboxycyclohexane-2-acetic acid. An isomer of the degradation product of abietic acid

A synthesis of 1,3-dimethyl-1,3-dicarboxycyclohexane-2-acetic acid has been described, and proved to be an isomer of the C12-acid-an oxidative degradation product of abietic acid.

Synthesis of cyclohexylideneacetaldehyde 2-, 3- and 4-methylcyclohexylideneacetaldehyde

Cyclohexanone and 2-, 3- and 4-methylcyclohexanones have been condensed with acetylene to give the respective 1-ethinylcyclohexanola. The 1-ethinylcyclohexanols were hydrogenated to the respective 1-vinyl- and 1-ethylcyclohexanols. The 1-vinylcyclohexanols have been treated with phosphorus tribromide to give the corresponding rearranged β-cyclohexylidenethyl bromides which have been converted to the pyridinium salts. The latter were treated with p-nitrosodimethylaniline and alkali (Krohnke's method) to give the corresponding nitrones which were hydrolyzed to the corresponding aldehydes. The 1-ethinyl-, 1-vinyl- and 1-ethylcyclohexanols prepared were subjected to pharmacological tests.

Isomerisations of substituted β-keto-esters - Part II. Isomerisation of ethyl 1-ethoxycarbonyl 2oxocyclopentyl acetate into 2, 3-diethoxycarbonylcyclohexanone

A mechanism for the isomerisation of ethyl 1-ethoxycarbonyl-2-oxocyclopentylacetate (I) into a cyclohexane β-keto-ester as proceeding through an intermediate bicyclic /gb-diketone (VII) has been considered as an alternative mechanism to one earlier suggested.1 The determination of the structure of the isomerised β-keto-ester as 2, 3-diethoxycarbonylcyclohexanone (V) has provided support for the earlier mechanism.

Synthesis, aggregation behavior and cholesterol solubilization studies of 16-epi-pythocholic acid (3 alpha,12 alpha,16 beta-trihydroxy-5 beta-cholan-24-oic acid)

Synthesis, aggregation behavior and in vitro cholesterol solubilization studies of 16-epi-pythocholic acid (3 alpha,12 alpha,16 beta-trihydroxy-5 beta-cholan-24-oic acid, EPCA) are reported. The synthesis of this unnatural epimer of pythocholic acid (3 alpha,12 alpha,16 alpha-trihydroxy-5 beta-cholan-24-oic acid, PCA) involves a series of simple and selective chemical transformations with an overall yield of 21% starting from readily available cholic acid (CA). The critical micellar concentration (CMC) of 16-epi-pythocholate in aqueous media was determined using pyrene as a fluorescent probe. In vitro cholesterol solubilization ability was evaluated using anhydrous cholesterol and results were compared with those of other natural di-and trihydroxy bile acids. These studies showed that 16-epi-pythocholic acid (16 beta-hydroxy-deoxycholic acid) behaves similar to cholic acid (CA) and avicholic acid (3 alpha,7 alpha,16 alpha-trihydroxy-5 beta-cholan-24-oic acid, ACA) in its aggregation behavior and cholesterol dissolution properties. (C) 2010 Elsevier Inc. All rights reserved.

1-[2,4,6-Trimethyl-3,5-bis(4-oxopiperidin ylmethyl) benzyl ]piperidin- 4-one

In the structure of the title compound, C27H39N3O3, each of the (4-oxopiperidin-1-yl)methyl residues adopts a flattened chair conformation (with the N and carbonyl groups being oriented to either,side of the central C-4 plane) and they occupy positions approximatelym orthogonal to the central benzene ring [C-benzene-C-C-methylene-N torsion angles 103.4 (2), -104.4 (3) and 71.9 (3)degrees]; further, two of these residues are oriented to one side of the central benzene ring with the third to the other side. In the crystal packing, supramolecular layers in the ab plane are sustained by C-H center dotcenter dot center dot O interactions.

Methyl 1-methyl-1H-1,2,3-triazole-4-carboxylate

The title molecule, C5H7N3O2, has an almost planar conformation, with a maximum deviation of 0.043 (3) angstrom, except for the methyl H atoms. In the crystal structure, intermolecular C-H center dot center dot center dot O hydrogen bonds link the molecules into layers parallel to the bc plane. Intermolecular pi-pi stacking interactions [centroid-centroid distances = 3.685 (2) and 3.697 (2) angstrom] are observed between the parallel triazole rings.

3-tert-Butyl-1H-isochromene-1-thione

The title compound, C13H14OS, crystallizes with two independent molecules in the asymmetric unit. The unit cell contains three voids of 197 angstrom(3), but the residual electron density (highest peak = 0.24 e angstrom(-3) and deepest hole = -0.18 e angstrom(-3)) in the difference Fourier map suggests no solvent molecule occupies this void. The crystal structure is stabilized by pi-pi interactions between the isocoumarin ring systems, with centroid-centroid distances of 3.6793 (14) and 3.6566 (15) angstrom.